FDA Approves Sanofi’s Meningococcal Meningitis Vaccine

The U.S. Food and Drug Administration (FDA) has greenlit Sanofi’s MenQuadfi Meningococcal Conjugate Vaccine for the prevention of invasive meningococcal disease in individuals at least two years old, the company announced this morning.